Agios Pharmaceuticals, Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
AGIO on Nasdaq
Location
88 Sidney Street, Cambridge, MA

Insiders trading volume in the past year

Agios Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Schenkein Director $10.1M Jun 20, 2024
Brian Goff Chief Executive Officer, Director $9.21M -$1.49M -14% Aug 8, 2025
Jacqualyn A. Fouse Director $4.13M -$194K -4.49% Jun 18, 2025
Sarah Gheuens Chief Medical Officer $2.78M -$832K -23.1% Jul 9, 2025
Cecilia Jones Chief Financial Officer $1.65M -$275K -14.3% Sep 26, 2025
James Burns Chief Legal Officer $1.36M -$1.37M -50.2% Jun 24, 2025
Tsveta Milanova Chief Commercial Officer $1.28M -$243K -16% Jun 24, 2025
Jonathan Biller Chief Financial Officer $966K Mar 1, 2022
Krishnan Viswanadhan Chief Corp Dev & Strategy $864K Mar 5, 2025
David Scadden Director $808K -$81.3K -9.14% Sep 30, 2025
Bruce Car Chief Scientific Officer $796K Mar 1, 2022
John Maraganore Director $741K Dec 31, 2022
Cynthia Smith Director $586K Aug 11, 2025
Rahul Ballal Director $586K -$1.12M -65.6% Aug 11, 2025
Maykin Ho Director $569K Jun 18, 2025
Kaye I. Foster-Cheek Director $368K Jun 18, 2025
Christopher Bowden Chief Medical Officer $335K Jun 18, 2021
E. Owen Director $269K Jun 18, 2025
Jeffrey Capello Director $269K Jun 18, 2025
Paul J. Clancy Director $265K Jun 21, 2022
Richa Poddar Chief Commercial Officer $225K Oct 15, 2022
Theodore James Jr. Washburn Principal Accounting Officer $201K -$495K -71.2% Sep 5, 2025
Darrin Miles Chief Commercial Officer $156K May 14, 2021
Ian T. Clark Director $142K May 20, 2022
Carman Alenson Principal Accounting Officer Jun 21, 2021
Jay Backstrom Director Jul 8, 2025

Recent Insider Transactions by Companies or Individuals for Agios Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.